Couldn't agree more..
My favourite part of the presentation:
"Competitive products with less ideal safety profiles and potentially poorer efficacy generate morethan US$1.5bn per annum between them in revenue.."
We've also seen what BTX1801 has in store, skin infections.
This company is as diversified as they come in this space and as innovative as any around.
Loved those market cap comparisons. That's why I keep saying 10 bags from here is conservative.
Just brilliant.
Cheap as chips, page-2
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.005(1.59%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 32.5¢ | 31.0¢ | $1.169M | 3.655M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 274982 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 48600 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
